Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Implantable Collamer Lens Market Growth in 2025?

The market for implantable collamer lenses has seen significant expansion in the past few years. The market’s size is projected to increase from $19.53 billion in 2024 to $20.91 billion in 2025, with a compound annual growth rate (CAGR) of 7.10%. The previous period’s growth can be credited to a heightened understanding of vision correction alternatives, a surge in the acceptance of minimally invasive surgeries, an escalation in the incidences of refractive errors, beneficial reimbursement schemes in crucial locations, and boosted funding in ophthalmic investigation.

What Is the Forecast for the Implantable Collamer Lens Market Size Through 2029?

The market size of implantable collamer lenses is projected to experience robust growth in the coming years, reaching a value of $27.25 billion in 2029 with a compound annual growth rate (CAGR) of 6.84%. This anticipated growth during the forecast period is attributed to a surge in demand for long-term vision correction solutions, an increased prevalence of conditions such as myopia and astigmatism, a heightened emphasis on tailored and patient-centric implants, an aging demographic requiring enhanced eyecare, and growth in outpatient surgical centres. Key trends predicted for the forecast period encompass the incorporation of AI into preoperative preparations, the creation of foldable and biocompatible lens materials, cooperation between manufacturing companies and healthcare providers, innovative advancements in lens material and designs, and progress in implantable lens technology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20840&type=smp

What are the Key Market Players in Implantable Collamer Lens Market and How They’re Evolving?

Major companies operating in the implantable collamer lens market are STAAR Surgical Company

What Are the Primary Growth Drivers in the Implantable Collamer Lens Market?

The upward trend in vision impairments is likely to boost the implantable collamer lens market’s momentum. The term “vision disorders” pertains to situations that negatively impact the capacity to see, marked by the steady diminishing of visual sharpness and ocular health. With the universal upsurge in ailments such as myopia and age-related macular degeneration, catalyzed by elements like an aging populace, an increase in screen time, and vision disorders are on the rise. Implantable Collamer Lenses (ICLs) offer a safe, reversible alternative to traditional refractive surgeries like LASIK, thus presenting a viable remedy for rectifying vision impairments likened to myopia, hyperopia, and astigmatism. For example, over 2.2 billion people suffer from vision impairment globally, with 1 billion of these cases being either preventable or yet to be addressed, as reported by the World Health Organization in August 2023. As per the Welsh Government, there were an estimated 1,563 new certificates of vision impairment issued in 2021-22, which is a rise of 49.1% from the previous year. Hence, the increasing prevalence of vision disorders is accelerating the advancement of the implantable collamer lens market. The Impact Of The Aging Demographics On The Implantable Collamer Lens Market Growth

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20840&type=smp

What Are the Leading Segments in the Global Implantable Collamer Lens Industry?

The implantable collamer lens market covered in this report is segmented –

1) By Type: Visian Implantable Collamer Lens (ICL), EVO Implantable Collamer Lens (ICL)

2) By Technology Adoption: Laser-Assisted Techniques, Traditional Techniques

3) By Application: Myopia, Hyperopia, Astigmatism

4) By End User: Ophthalmic Clinics, Hospitals, Ambulatory Surgical Center, Other End User

Subsegments:

1) By Visian Implantable Collamer Lens (ICL): Visian ICL for Myopia, Visian ICL For Hyperopia, Visian ICL For Astigmatism, Visian ICL For Presbyopia

2) By EVO Implantable Collamer Lens (ICL): EVO ICL For Myopia, EVO ICL For Hyperopia, EVO ICL For Astigmatism, EVO ICL For Presbyopia

What Are the Key Market Trends in the Implantable Collamer Lens Industry?

Significant firms in the Implantable Collamer Lens (ICL) market are concentrating on innovations in lens technology and acquiring official sanctions to enhance their industry dominance. The Implantable Collamer Lens aids in correcting refractive visual inaccuracies and presents a minimally invasive remedy for myopia and astigmatism. For example, the U.S Food and Drug Administration (FDA) gave its approval to the EVO/EVO+ Visian Implantable Collamer Lens (EVO) in April 2022 as disclosed by STAAR Surgical Company. This U.S-based firm specializes in the production and marketing of implantable lenses and their associated delivery systems for the eye. The EVO Visian ICL lens can correct or decrease nearsightedness within the range of -3.0 D to -20.0 D, and treat astigmatism between 1.0 D and 4.0 D.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/implantable-collamer-lens-global-market-report

What Is the Regional Outlook for the Implantable Collamer Lens Market?

North America was the largest region in the implantable collamer lens market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable collamer lens market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20840

This Report Delivers Insight On:

1. How big is the implantable collamer lens market, and how is it changing globally?

2. Who are the major companies in the implantable collamer lens market, and how are they performing?

3. What are the key opportunities and risks in the implantable collamer lens market right now?

4. Which products or customer segments are growing the most in the implantable collamer lens market?

5. What factors are helping or slowing down the growth of the implantable collamer lens market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model